KENNEDY CAPITAL MANAGEMENT LLC – Iovance Biotherapeutics, Inc. Transaction History
KENNEDY CAPITAL MANAGEMENT LLC portfolio value:
$6.45M
portfolio value
KENNEDY CAPITAL MANAGEMENT LLC quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.38% | 9.17K shares | -883K | $9.58 | 673.62K |
| Q2 2022 | share | Increase | +53.29% | 230.99K shares | 119K | $11.04 | 664.44K |
| Q1 2022 | share | Increase | +5.03% | 20.75K shares | -661K | $16.65 | 433.45K |
| Q4 2021 | share | Decrease | -2.71% | -11.50K shares | -2.58M | $19.42 | 412.7K |
| Q3 2021 | share | Increase | +12.54% | 47.28K shares | 654K | $24.66 | 424.20K |
| Q2 2021 | share | Increase | +906.92% | 339.48K shares | 8.62M | $26.02 | 376.91K |
| Q1 2021 | share | Decrease | -9.13% | -3.75K shares | -726K | $31.66 | 37.43K |
| Q4 2020 | share | Decrease | -0.95% | -397 shares | 542K | $46.4 | 41.19K |
| Q3 2020 | share | Decrease | -0.76% | -319 shares | 219K | $32.92 | 41.58K |
| Q2 2020 | share | Increase | +0.67% | 280 shares | -96K | $27.45 | 41.90K |
| Q1 2020 | share | Decrease | -20.96% | -11.03K shares | -212K | $29.94 | 41.62K |
| Q4 2019 | share | Decrease | -0.87% | -461 shares | 491K | $27.68 | 52.66K |
| Q3 2019 | share | Decrease | -28.83% | -21.52K shares | -863K | $18.2 | 53.12K |
| Q2 2019 | share | Increase | 0.00% | 74.65K shares | 1.83M | $24.52 | 74.65K |